PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...

Studies investigating the results of treatments through conventional light microscopy histology in human nonalcoholic fatty liver disease ... necroinflammation and ballooning at light microscopy.

Specifically, it will serve as an aid to trial pathologists in scoring liver biopsies at enrollment ... for lobular inflammation and hepatocellular ballooning. This qualification signifies a ...

Liver fibrosis was staged ... fibrosis staged according to the NASH Clinical Research Network and modified Ishak fibrosis classifications, and grading of steatosis, lobular inflammation and ...

However, some people experience fatigue, abdominal discomfort, or unexplained weight loss. Over time, it can progress to non-alcoholic steatohepatitis (NASH), liver fibrosis, or even liver failure.

Hypothyroidism, for example, might lead to NASH, cirrhosis and potentially liver cancer via the development of hyperlipidemia and obesity. Patients with growth hormone deficiency have a metabolic ...

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

To assess the severity of fibrosis, biomarker scores are used with elastography, which measures liver stiffness. However, the key microscopic features of MASLD, such as ballooning or lobular ...